Centre forms committee to examine WHO details on 66 kid deaths in The Gambia
Darpan News Desk IANS, 12 Oct, 2022 11:00 AM
New Delhi, Oct 12 (IANS) The Centre has formed a four-member panel to examine the detailed report shared by the World Health Organisation on 66 children's deaths in The Gambia reportedly after using Indian-made medicines.
"The committee will examining and analysing adverse event reports, causal relationship, and all related details shared by WHO. After examining, the committee will suitably advise and recommend the Drug Controller General of India (DCGI) about further course of action. The committee may co-opt any other technical expert as deemed necessary, an official source told IANS.
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines. The other members are Dr Pragya D. Yadav, NIV, ICMR, Pune, Dr Arti Bahl, Division of Epidemiology, NCDC, New Delhi, and A.K. Pradhan, JDC(I), CDSCO.
The WHO has informed that as per the tentative results received by it, out of the 23 samples of the products under reference which were tested, four samples have been found to contain Diethylene Glycol/Ethylene Glycol.
However, the global health body has not yet made available the certificate of analysis. It has informed that the same will be made available in near future. The exact one to one causal relation of death has not yet been provided by the WHO to the Central Drugs Standard Control Organisation (CDSCO) although it has requested the global health body twice in this regard, sources told IANS.
After the CDSCO launched a detailed investigation to ascertain the facts, the preliminary enquiry has revealed that Maiden Pharmaceutical Ltd, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup, and MaGrip n Cold Syrup under reference, and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to The Gambia.
Meanwhile, the CDSCO and State Drug Controller Haryana have stopped all the manufacturing activities of Maiden Pharmaceuticals Ltd at Sonepat on October 11 on grounds of deficiencies found on local inspection.
During the previous hearing, Malik told the Court that he was not contesting the charges levelled against him. He may not even challenge the sentencing in higher courts as he has himself pleaded guilty which means by all means, Malik will spend the rest of his life in Jail.
Cheema said school children from Punjab had fared better than their counterparts in Delhi when compared class wise right from class three, class five, class eight and class 10. He said Punjab students has stood first as far as comprehending mathematics was concerned, second in case of social sciences and third in case of English.
Lauding this farmer-friendly initiative, Mann said it would be instrumental to compile the entire data about each and every farmer, who has opted for DSR technique besides ensuring payment of Rs 1,500 per acre after proper verification through this portal to the genuine beneficiaries in a fair and transparent manner.
In the arguments before the sentencing, Malik told the court that he will accept hanging if the intelligence agencies prove any terror-related activities involving him.
Kejriwal along with Transport Minister Kailash Gahlot also took a ride on board an electric bus from the Indraprastha Depot to Rajghat after flagging off the fleet.
Though the bench of Justice Anu Malhotra issued a notice in the kidnapping matter, it did not issue any notice in another petition filed by the Punjab government seeking quashing of a Delhi Court order for finding Bagga which led to his release from the Punjab Police's custody. The matter will be heard in detail further on May 26.
